Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Breast Neoplasms × durvalumab × Clear all

Phase

Status

Completed 18 Active not recruiting 15 Recruiting 8 Terminated 3 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 6 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Colorectal Neoplasms 3 Urinary Bladder Neoplasms 2 Carcinoma, Renal Cell 2 Uveal Melanoma 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Breast Cancer Female 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1 Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 28 Trastuzumab 22 Cyclophosphamide 21 Doxorubicin 14 Docetaxel 14 Carboplatin 11 exemestane 10 Radiotherapy 10 Letrozole 10 Capecitabine 10 pembrolizumab 8 Lapatinib 8 Fulvestrant 8 Neoadjuvant Therapy 6 Goserelin 6 Bevacizumab 6 Anastrozole 6 pertuzumab 5 palbociclib 5 eribulin 5 abemaciclib 5 Therapeutics 5 Magnetic Resonance Spectroscopy 5 Epirubicin 5 Aromatase Inhibitors 5 tucatinib 4 Vinorelbine 4 Taxes 4 Tamoxifen 4 Saline Solution 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03872505 2021-08-25

PANDoRA

Cedars-Sinai Medical Center

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡